Cadila receives USFDA approval to market Tadalafil in US
Zydus Cadila has received final USFDA approval to market Tadalafil tablets in American markets. The drug Tadalafil is used to erectile dysfunction and enlarged prostrate. […]
Month: June 2018
Lupin receives USFDA approval for Drospirenone, Ethinyl Estradiol, Levomefolate
Lupin has received USFDA approval to market Drospirenone, Ethinyl Estradiol, Levomefolate Calcium tablets in the American market. The drug is a generic version of Bayer […]
NPPA fixes drugs of 22 formulations for bacterial infections, cardiac conditions etc.,
National Pharma Pricing Authority (NPPA) has fixed the retail and ceiling prices of 22 formulations used for treatment of various ailments including HIV, bacterial infections […]
Natco Pharma launches Posanat – antifungal injection
Natco Pharma has launched generic version of Posaconazole Injection, 300 mg/16.7ml, under its brand POSANAT. It may be noted, the drug is available for the […]
Challenges faced by bulk drug manufacturers in India
India produces over 1/5th of bulk drug production in the world. However, the bulk drugs manufacturers are facing regulatory hurdles in many area. Currently, irrespective […]
Cipla signs agreement with Stempeutics Research for Stempeucel
Cipla Ltd has signed an agreement with biotech firm Stempeutics Research for its stem cell therapy product Stempeucel, indicated for treating critical limb ischemia. Under […]
Granules Pharma launches Methylergonovine Maleate Tablets in US market
Granules Pharmaceuticals, a subsidiary of Granules India , has launched the generic version of Methylergonovine Maleate Tablets in US markets. The company will market the […]